Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Adacel Vaccine in 10-Year-Olds
NCT01311557Phase 4Completed
- Sponsor
- Sanofi
- Start
- Mar 2011
- Primary completion
- Nov 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of acellular pertussis vaccine in Tetanus, diphtheria, pertussis, sponsored by Sanofi. Started Mar 2011; status: completed.
02
Drugs
acellular pertussis vaccine
03
Conditions
Tetanusdiphtheriapertussis
Beyond the preview
Go deeper on NCT01311557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01311557.